NCT02100657 - Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions

Multiple Myeloma

Interventions

DRUG

Plitidepsin

DRUG

Bortezomib

DRUG

Dexamethasone

Trial Locations (7)

MD Anderson Cancer Center Madrid, Madrid

Clínica Universidad de Navarra, Pamplona

Hospital Universitario Salamanca, Salamanca

Hospital Universitario Virgen del Rocío, Seville

Hospital Universitari i Politècnic la Fe, Valencia

Institut Gustave Roussy, Villejuif

Hospital Universitario Germans Trias I Pujol, Badalona